Background And Purpose: Aside from the enhancement of physical dose deposited by antiprotons annihilating in tissue-like material compared to protons of the same range a further increase of biological effective dose has been demonstrated. This enhancement can be expressed in an increase of the relative biological effectiveness (RBE) of antiprotons near the end of range. We have performed the first-ever direct measurement of the RBE of antiprotons both at rest and in flight.
Materials And Methods: Experimental data were generated on the RBE of an antiproton beam entering a tissue-like target consisting of V79 cells embedded in gelatin with an energy providing a range of approximately 10cm.
Results: The RBE in the entrance channel (the "plateau") is only slightly above the value for a comparable proton beam, and remains low until the proximal edge of the spread-out Bragg peak (SOBP). A steep increase of RBE is seen starting from the onset of the SOBP.
Conclusions: This paper reports the final results of the experiment AD-4/ACE at CERN on the first-ever direct measurement of RBE of antiprotons and constitutes the first step toward developing treatment plans.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.radonc.2016.12.007 | DOI Listing |
Phys Med Biol
September 2022
Radiological Physics and Advisory Division, Health, Safety and Environment Group, Bhabha Atomic Research Centre, Mumbai-400085, India.
. This study aims at comparing dosimetric parameters of 126 MeV antiprotons and protons using microdosimetric approach..
View Article and Find Full Text PDFSci Rep
August 2020
Department of Physics, Faculty of Science, Ryerson University, 350 Victoria St., Toronto, ON, M5B 2K3, Canada.
This study investigates the photon production from thermal neutron capture in a gadolinium (Gd) infused tumor as a result of secondary neutrons from particle therapy. Gadolinium contrast agents used in MRI are distributed within the tumor volume and can act as neutron capture agents. As a result of particle therapy, secondary neutrons are produced and absorbed by Gd in the tumor providing potential enhanced localized dose in addition to a signature photon spectrum that can be used to produce an image of the Gd enriched tumor.
View Article and Find Full Text PDFRadiother Oncol
December 2016
Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark.
Background And Purpose: Aside from the enhancement of physical dose deposited by antiprotons annihilating in tissue-like material compared to protons of the same range a further increase of biological effective dose has been demonstrated. This enhancement can be expressed in an increase of the relative biological effectiveness (RBE) of antiprotons near the end of range. We have performed the first-ever direct measurement of the RBE of antiprotons both at rest and in flight.
View Article and Find Full Text PDFSci Rep
February 2014
Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
Biological validation of new radiotherapy modalities is essential to understand their therapeutic potential. Antiprotons have been proposed for cancer therapy due to enhanced dose deposition provided by antiproton-nucleon annihilation. We assessed cellular DNA damage and relative biological effectiveness (RBE) of a clinically relevant antiproton beam.
View Article and Find Full Text PDFJ Xray Sci Technol
December 2011
University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Radiation therapy using antiprotons is a potential interesting future modality. Energetic antiprotons penetrate matter with almost near identical stopping powers and radio biological effectiveness (RBE) as protons in the region well before the Bragg peak region. When the antiprotons come to rest at or near the Bragg peak, they annihilate releasing almost 2 GeV per annihilation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!